Mulay James — Insider transactions, Director at CG Oncology, Inc. / Fulgent Genetics, Inc. | InsiderLens

FrançaisSign in Try free 14d

Mulay James

USNatural personDirector

Transactions

38

Issuers

2

Buys / Sells

0/13

Last tx

17 Apr 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CG Oncology, Inc.	15,600	reported	17 Apr 2026	tx 35+136,833−194,136
Fulgent Genetics, Inc.	5,000	reported	30 May 2019	tx 4+20,000

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
17 Apr 2026	EXERCISE	CG Oncology, Inc.	15,600	36.63 USD
17 Apr 2026	SALE	CG Oncology, Inc.	15,600	73.01 USD
17 Apr 2026	EXERCISE	CG Oncology, Inc.	15,600	0.00 USD	deriv
16 Mar 2026	EXERCISE	CG Oncology, Inc.	1,310	12.59 USD
16 Mar 2026	EXERCISE	CG Oncology, Inc.	654	3.72 USD
16 Mar 2026	SALE	CG Oncology, Inc.	654	63.50 USD
16 Mar 2026	SALE	CG Oncology, Inc.	1,310	63.50 USD
16 Mar 2026	EXERCISE	CG Oncology, Inc.	654	0.00 USD	deriv
16 Mar 2026	EXERCISE	CG Oncology, Inc.	1,310	0.00 USD	deriv
09 Jan 2026	SALE	CG Oncology, Inc.	10,491	52.99 USD
09 Jan 2026	SALE	CG Oncology, Inc.	654	44.16 USD
09 Jan 2026	EXERCISE	CG Oncology, Inc.	654	3.72 USD
09 Jan 2026	EXERCISE	CG Oncology, Inc.	10,491	12.59 USD
09 Jan 2026	EXERCISE	CG Oncology, Inc.	10,491	0.00 USD	deriv
09 Jan 2026	EXERCISE	CG Oncology, Inc.	654	0.00 USD	deriv
09 Oct 2025	SALE	CG Oncology, Inc.	5,903	43.99 USD
09 Oct 2025	EXERCISE	CG Oncology, Inc.	5,903	3.72 USD
09 Oct 2025	EXERCISE	CG Oncology, Inc.	5,903	0.00 USD	deriv
29 Sept 2025	EXERCISE	CG Oncology, Inc.	12,755	1.82 USD
29 Sept 2025	SALE	CG Oncology, Inc.	12,755	39.19 USD
29 Sept 2025	EXERCISE	CG Oncology, Inc.	12,755	0.00 USD	deriv
19 Sept 2025	SALE	CG Oncology, Inc.	3,574	38.99 USD
19 Sept 2025	EXERCISE	CG Oncology, Inc.	3,574	0.00 USD	deriv
18 Sept 2025	EXERCISE	CG Oncology, Inc.	19,112	0.00 USD	deriv
18 Sept 2025	EXERCISE	CG Oncology, Inc.	19,112	1.82 USD